Market Tracker

03/03 6:02pm ET

Novavax Inc (NASDAQ:NVAX)

During the Trading Day
8.57 -0.35 / -3.92%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
8.58 +0.01 / +0.12%
 
Volume: 38.9K
Frontrunning: February 27
Feb 27 / Investing Channel
 

Today’s Trading

Previous close8.92
Today’s open8.85
Day’s range8.38 - 8.89
Volume10,857,527
Average volume (3 months)5,129,469
Market cap$2.1B
Dividend yield--
Data as of 3:59pm ET, 03/03/2015

Growth & Valuation

Earnings growth (last year)-40.91%
Earnings growth (this year)-2.45%
Earnings growth (next 5 years)0.00%
Revenue growth (last year)-5.26%
P/E ratioNM
Price/Sales41.53
Price/Book9.16

Competitors

 Today’s
change
Today’s
% change
HALOHalozyme Therapeutic...+0.01+0.07%
OPHTOphthotech Corp-0.08-0.15%
RDUSRadius Health Inc-0.31-0.70%
RLYPRelypsa Inc-0.34-0.88%
Data as of 4:00pm ET, 03/03/2015

Financials

Next reporting dateMay 11, 2015
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$20.9M
Annual profit (last year)-$52.0M
Net profit margin-248.54%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stanley C. Erck
Chief Financial Officer, Treasurer &
Senior VP
Barclay A. Phillips
Corporate headquarters
Gaithersburg, Maryland

Forecasts